与高龄老人阿尔茨海默病神经病理改变缺失相关的病史:90+研究
该研究回顾性分析90岁及以上参与者(267人,平均死亡年龄98岁)的病史与用药,采用逻辑回归估计其与神经炎性斑块、β淀粉样斑块及神经原纤维缠结存在的比值比。结果显示心脏病、ACE抑制剂、白内障、β受体阻滞剂等与不同病理改变缺失相关,但作者指出这些观察无法通过多重比较校正,并需考虑生存偏倚和1型错误。
要点
- 在90岁及以上人群中,心脏病与神经炎性斑块(aOR=0.46)和β淀粉样斑块(aOR=0.33)存在负相关。
- ACE抑制剂与神经炎性斑块(aOR=0.46)和神经原纤维缠结(aOR=0.46)存在负相关。
- 白内障与神经炎性斑块(aOR=0.26)负相关,β受体阻滞剂与神经炎性斑块(aOR=0.51)负相关。
核心结论
- 白内障形成、APOE状态、ACE抑制剂和β受体阻滞剂可能因脂质转运差异而与ADNC缺失相关。
- 这些观察无法通过多重比较校正,需考虑生存偏倚和1型错误。
研究设计与样本
- 回顾性分析90+研究(基于加利福尼亚的纵向研究)中年龄≥90岁参与者的数据。
- 共检查267名参与者,75%为女性,平均死亡年龄98(±3.5)岁。
- 对神经炎性斑块(任何)、β淀粉样斑块(Thal phase > 0)和神经原纤维缠结(>2)进行神经病理学分析。
主要发现
- 神经炎性斑块:心脏病(aOR=0.46)、ACE抑制剂(aOR=0.46)、白内障(aOR=0.26)、β受体阻滞剂(aOR=0.51)与缺失相关;APOE-ε4(aOR=3.48)与存在相关。
- β淀粉样斑块:心脏病(aOR=0.33)与缺失相关;APOE-ε4(aOR=8.10)与存在相关。
- 神经原纤维缠结:ACE抑制剂(aOR=0.46)、青光眼(aOR=0.29)、高血压(aOR=0.44)、癫痫(aOR=0.16)、APOE-ε2存在(aOR=0.39)、血管扩张剂(aOR=0.36)与缺失相关。
- 上述观察无法通过多重比较校正。
临床怎么用
- 原文未据此给出推荐。
局限性
- 生存偏倚和1型错误需要加以考虑。
- 这些观察无法通过多重比较校正。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Exploration of medical histories and medications associated with Alzheimer disease neuropathologic change (ADNC) absence and potential resistance may identify protective factors against ADNC. This was a retrospective examination of data from participants age ≥90 years who enrolled in The 90+ Study, a longitudinal study based in California. Participants underwent neuropathologic analysis for the presence of neuritic amyloid plaques (NPs) (any), beta amyloid plaques (Thal phase > 0), and neurofibrillary tangles (>2). Odds ratios (ORs) for the presence of pathologic changes to APOE genotype, self-reported medical histories, and medication use were estimated by logistic regression and (a)djusted for sex, age at death (continuous), and education. RESULTS: We examined 267 participants; 75% were female, with a mean age at death of 98 (± 3.5) years. Variables associated with ADNC absence/presence were for NPs: heart disease (adjusted OR [aOR] = 0.46), APOE-ε4 (aOR = 3.48), angiotensin-converting enzyme (ACE) inhibitors (aOR = 0.46), cataracts (aOR = 0.26), and beta-blockers (aOR = 0.51); for Aβ: heart disease (aOR = 0.33) and APOE-ε4 (aOR = 8.10); and for neurofibrillary tangles: ACE inhibitors (aOR = 0.46), glaucoma (aOR = 0.29), HTN (aOR = 0.44), seizures (aOR = 0.16), APOE-ε2 presence (aOR = 0.39), and vasodilators (aOR = 0.36). These observations would not survive multiple comparison corrections. DISCUSSION: Cataract formation, APOE status, ACE inhibitors, and beta-blockers may be associated with ADNC absence because of differential lipid trafficking. Survival bias and type 1 errors warrant consideration.
引用
- Lee S, Rajmohan R, Al-Darsani Z, et al. Medical Histories Associated With Absence of Alzheimer Disease Neuropathologic Changes in the Oldest-Old: The 90+ Study. Neurology. 2024. PMID: 39666918. doi:10.1212/WNL.0000000000210107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。